Future of Regulation and Access UK | BIA
| jeudi 03 décembre 2026 |
| 08:45 - 07:00 Greenwich Mean Time |
Morgan Lewis is pleased to sponsor the BioIndustry Association’s Future of Regulation and Access UK 2026 conference, taking place on December 3, 2026 in London.
FDA and healthcare partner Jackie Mulryne and associate Lexi Stefanatos will attend the event, which brings together senior leaders, industry authorities, and policymakers to discuss key regulatory developments and challenges shaping the future of the UK life sciences sector.
The conference will explore the evolving regulatory landscape for clinical trials, medicines regulation, market access, and reimbursement, with a focus on supporting innovation and improving patient access to new treatments. Discussions will examine how regulatory frameworks, healthcare adoption, and policy developments can work together to advance the UK life sciences industry.
The event will bring together representatives from the government, regulatory bodies, and the pharmaceutical and biotechnology sectors, providing opportunities to exchange insights on emerging challenges, share best practices, and explore the future of regulation and patient access in the United Kingdom.